S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Better Than Oil Stocks (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Better Than Oil Stocks (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Better Than Oil Stocks (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Better Than Oil Stocks (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Better Than Oil Stocks (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Better Than Oil Stocks (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Better Than Oil Stocks (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Better Than Oil Stocks (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
NASDAQ:BMRN

BioMarin Pharmaceutical (BMRN) Earnings Date, Estimates & Call Transcripts

$88.48
-0.77 (-0.86%)
(As of 09/29/2023 08:52 PM ET)
Compare
Today's Range
$88.34
▼
$89.94
50-Day Range
$86.27
▼
$94.48
52-Week Range
$80.53
▼
$117.77
Volume
1.64 million shs
Average Volume
1.31 million shs
Market Capitalization
$16.65 billion
P/E Ratio
170.16
Dividend Yield
N/A
Price Target
$115.62
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Oct. 25Estimated
Actual EPS
(Jul. 31)
$0.34 Beat By $0.10
Consensus EPS
(Jul. 31)
$0.24
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BMRN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BMRN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioMarin Pharmaceutical Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$0.16$0.38$0.30 
Q2 20233$0.24$0.54$0.35 
Q3 20235$0.11$0.29$0.21 
Q4 20235$0.24$0.41$0.30 
FY 202316$0.75$1.62$1.16 
Q1 20242$0.43$0.44$0.44 
Q2 20242$0.46$0.61$0.54 
Q3 20242$0.46$0.81$0.64 
Q4 20242$0.51$0.95$0.73 
FY 20248$1.86$2.81$2.34 
Q1 20251$0.58$0.58$0.58 
Q2 20251$0.61$0.61$0.61 

BMRN Earnings Date and Information

BioMarin Pharmaceutical last posted its quarterly earnings results on July 31st, 2023. The biotechnology company reported $0.34 EPS for the quarter, beating analysts' consensus estimates of $0.24 by $0.10. The firm had revenue of $595.28 million for the quarter, compared to analysts' expectations of $591.46 million. BioMarin Pharmaceutical has generated $0.52 earnings per share over the last year ($0.52 diluted earnings per share) and currently has a price-to-earnings ratio of 170.2. Earnings for BioMarin Pharmaceutical are expected to grow by 105.60% in the coming year, from $1.25 to $2.57 per share. BioMarin Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 25th, 2023 based off prior year's report dates.

BioMarin Pharmaceutical Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/25/2023
Estimated)		------- 
7/31/2023Q2 2023$0.24$0.34+$0.10$0.39$591.46 million$595.28 million
4/26/2023Q1 2023$0.24$0.39+$0.15$0.51$572.53 million$596.42 million
2/27/2023Q4 2022$0.12$0.11($0.01)$0.22$533.88 million$537.54 million
10/26/2022Q3 2022$0.12$0.16+$0.04$0.36$516.03 million$505.30 million      
8/3/2022Q2 2022$0.20$0.33+$0.13$0.51$514.18 million$533.80 million      
4/27/2022Q1 2022$0.15$0.31+$0.16($0.01)$505.11 million$519.36 million      
2/23/2022Q4 2021($0.22)($0.21)+$0.01($0.10)$442.38 million$449.81 million    
10/26/2021Q3 2021($0.25)($0.20)+$0.05$0.14$435.29 million$408.74 million    
7/27/2021Q2 2021($0.11)$0.07+$0.18$0.39$448.84 million$501.69 million      
4/28/2021Q1 2021$0.07$0.09+$0.02$0.49$445.44 million$486.03 million    
2/25/2021Q4 2020($0.06)$0.12+$0.18($0.22)$447.17 million$452.12 million    
11/5/2020Q3 2020($0.01)$4.01+$4.02($3.43)$454.64 million$476.78 million    












BioMarin Pharmaceutical Earnings - Frequently Asked Questions

When is BioMarin Pharmaceutical's earnings date?

BioMarin Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 25th, 2023 based off last year's report dates. Learn more on BMRN's earnings history.

Did BioMarin Pharmaceutical beat their earnings estimates last quarter?

In the previous quarter, BioMarin Pharmaceutical (NASDAQ:BMRN) reported $0.34 earnings per share (EPS) to beat the analysts' consensus estimate of $0.24 by $0.10. Learn more on analysts' earnings estimate vs. BMRN's actual earnings.

How much revenue does BioMarin Pharmaceutical generate each year?

BioMarin Pharmaceutical (NASDAQ:BMRN) has a recorded annual revenue of $2.10 billion.

How much profit does BioMarin Pharmaceutical generate each year?

BioMarin Pharmaceutical (NASDAQ:BMRN) has a recorded net income of $141.56 million. BMRN has generated $0.52 earnings per share over the last four quarters.

What is BioMarin Pharmaceutical's price-to-earnings ratio?

BioMarin Pharmaceutical (NASDAQ:BMRN) has a trailing price-to-earnings ratio of 170.16 and a forward price-to-earnings ratio of 70.78.

What is BioMarin Pharmaceutical's EPS forecast for next year?

BioMarin Pharmaceutical's earnings are expected to grow from $1.25 per share to $2.57 per share in the next year, which is a 105.60% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:BMRN) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -